• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患病率增加的证据:1999-2018 年德黑兰注册中心的一项基于人群的研究。

Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.

机构信息

Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran.

Multiple Sclerosis Research Center, Sina Hospital, Hassan Abad square, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

BMC Neurol. 2020 May 2;20(1):169. doi: 10.1186/s12883-020-01747-8.

DOI:10.1186/s12883-020-01747-8
PMID:32359352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7195783/
Abstract

BACKGROUND

The epidemiological characteristics of multiple sclerosis (MS) have been investigated in various studies, which have revealed that the prevalence of MS varies across countries. The present study was conducted to investigate the longitudinal prevalence of MS in Tehran, Iran.

METHODS

The present population-based study was conducted in Tehran, the capital of Iran from 1999 to 2018 based on the annual report data provided by the Iranian MS Society (IMSS) registry system. The age-standardized and crude prevalence were estimated using population data presented by the Statistical Centre of Iran.

RESULTS

A total of 21,580 MS cases were registered and included in the analysis. Among the participant patients, 24.99% (5393) and 75.01% (16,187) of cases were male and female, respectively. The mean age of MS onset was 28.8 years (S.D: 8.7). The age-standardized prevalence (ASP) of MS increased from 73.7 (95%CI: 72.1-75.2) per 100,000 people in 2006 to 137.6 (95% CI: 135.7-139.5) per 100,000 people in 2018. The ASP of MS in 2018 was estimated to be 67.9 (95%CI: 66.0-69.8) and 207.3 (95%CI: 204.0-210.7) per 100,000 people among males and females, respectively. The age-standardized female-to-male ratio of MS ranged from 3.7 (in 2010) to 2.06 (in 2017).

CONCLUSION

The findings of this study suggested that the prevalence of MS in Tehran province is relatively high, and the occurrence of the disease is more common in the age groups under 40 years as compared with older-aged groups. In line with reports provided for various regions of the world, the prevalence of MS was higher among women. Similarly, the findings of this study revealed that the female-to-male ratio was 2.14 in 2018.

摘要

背景

多项研究已经调查了多发性硬化症(MS)的流行病学特征,这些研究揭示了 MS 的患病率在各国之间存在差异。本研究旨在调查伊朗德黑兰的 MS 纵向患病率。

方法

本基于伊朗多发性硬化症协会(IMSS)注册系统提供的年度报告数据,在伊朗首都德黑兰进行了这项基于人群的研究。使用伊朗统计中心提供的人口数据,估算了年龄标准化和原始患病率。

结果

共登记了 21580 例 MS 病例,并纳入了分析。在参与者患者中,男性占 24.99%(5393 例),女性占 75.01%(16187 例)。MS 发病的平均年龄为 28.8 岁(标准差:8.7)。MS 的年龄标准化患病率(ASP)从 2006 年每 10 万人 73.7(95%CI:72.1-75.2)增加到 2018 年的每 10 万人 137.6(95%CI:135.7-139.5)。2018 年,男性和女性的 MS ASP 分别估计为每 10 万人 67.9(95%CI:66.0-69.8)和 207.3(95%CI:204.0-210.7)。MS 的年龄标准化女性与男性比值范围为 3.7(2010 年)至 2.06(2017 年)。

结论

本研究的结果表明,德黑兰省的 MS 患病率相对较高,与年龄较大的人群相比,疾病发生更常见于 40 岁以下的年龄组。与世界各地报告的数据一致,MS 在女性中的患病率更高。同样,本研究的结果表明,2018 年女性与男性的比例为 2.14。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f896/7195783/7f62ccd8f60e/12883_2020_1747_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f896/7195783/7f62ccd8f60e/12883_2020_1747_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f896/7195783/7f62ccd8f60e/12883_2020_1747_Fig1_HTML.jpg

相似文献

1
Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.多发性硬化症患病率增加的证据:1999-2018 年德黑兰注册中心的一项基于人群的研究。
BMC Neurol. 2020 May 2;20(1):169. doi: 10.1186/s12883-020-01747-8.
2
Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series.伊朗德黑兰多发性硬化症的贝叶斯结构时间序列预测。
BMC Neurol. 2021 Jun 24;21(1):235. doi: 10.1186/s12883-021-02281-x.
3
Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.伊朗多发性硬化症家族复发患病率上升:基于德黑兰1999 - 2015年登记处的一项人群研究。
BMC Neurol. 2018 Feb 7;18(1):15. doi: 10.1186/s12883-018-1019-2.
4
A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.伊朗德黑兰多发性硬化症的 20 年发病趋势(1989-2008 年)和时点患病率(2009 年 3 月 20 日):一项基于人群的研究。
Neuroepidemiology. 2011;36(3):141-7. doi: 10.1159/000324708. Epub 2011 Apr 20.
5
Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999-2018.家族性多发性硬化症的流行病学:1999年至2018年在德黑兰开展的一项基于人群的研究。
Mult Scler Relat Disord. 2020 Aug;43:102178. doi: 10.1016/j.msard.2020.102178. Epub 2020 May 14.
6
Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?德黑兰的多发性硬化症:发病率稳定的同时患病率上升——是真实增长还是诊断水平提高?
Arch Iran Med. 2019 Aug 1;22(8):429-434.
7
Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran.伊朗德黑兰多发性硬化症的患病率和发病率
Iran J Public Health. 2017 May;46(5):699-704.
8
The incidence and prevalence of crude and familial multiple sclerosis in Tehran, Iran in 2021.2021年伊朗德黑兰原发性和家族性多发性硬化症的发病率及患病率。
Neurol Sci. 2023 Dec;44(12):4517-4518. doi: 10.1007/s10072-023-07043-w. Epub 2023 Aug 29.
9
Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran.伊朗东北部拉扎维呼罗珊省多发性硬化症的发病率和患病率的时间趋势。
Neurol Sci. 2022 Jan;43(1):583-591. doi: 10.1007/s10072-021-05280-5. Epub 2021 May 3.
10
Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.伊朗伊斯法罕多发性硬化症发病率和患病率急剧上升。
Mult Scler. 2011 Aug;17(8):1022-7. doi: 10.1177/1352458511401460. Epub 2011 Apr 1.

引用本文的文献

1
Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis.体液免疫应答和多发性硬化症患者的 Sars-Cov-2 疫苗安全性。
BMC Immunol. 2024 Jun 19;25(1):35. doi: 10.1186/s12865-024-00628-w.
2
Economic and Social Standing of Individuals in Iran Diagnosed with Multiple Sclerosis.伊朗多发性硬化症患者的经济和社会地位。
Arch Iran Med. 2023 Aug 1;26(8):413-418. doi: 10.34172/aim.2023.63.
3
Challenges of patients with multiple sclerosis in receiving health care services in Iran.伊朗多发性硬化症患者在接受医疗服务方面面临的挑战。

本文引用的文献

1
Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?德黑兰的多发性硬化症:发病率稳定的同时患病率上升——是真实增长还是诊断水平提高?
Arch Iran Med. 2019 Aug 1;22(8):429-434.
2
Multiple sclerosis national registry system in Iran: Validity and reliability of a minimum data set.伊朗多发性硬化症国家登记系统:最小数据集的有效性和可靠性。
Mult Scler Relat Disord. 2019 Aug;33:158-161. doi: 10.1016/j.msard.2019.06.009. Epub 2019 Jun 9.
3
Economic burden of multiple sclerosis in a population with low physical disability.
Curr J Neurol. 2023 Jan 5;22(1):16-22. doi: 10.18502/cjn.v22i1.12612.
4
The psychometric properties of the Persian version of the Multiple Sclerosis Self-Management Scale-Revised: A cross-sectional methodological study.多发性硬化自我管理量表修订版波斯语版本的心理测量特性:一项横断面方法学研究。
Health Sci Rep. 2023 Aug 31;6(9):e1515. doi: 10.1002/hsr2.1515. eCollection 2023 Sep.
5
Relationship between medical history and multiple sclerosis: A-case-control study.病史与多发性硬化症的关系:病例对照研究。
Medicine (Baltimore). 2023 Jun 9;102(23):e33906. doi: 10.1097/MD.0000000000033906.
6
Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third Edition.全球多发性硬化症诊断障碍:多发性硬化症国际联合会 MS 图谱,第三版的数据。
Neurology. 2023 Aug 8;101(6):e624-e635. doi: 10.1212/WNL.0000000000207481. Epub 2023 Jun 15.
7
The relationship between coping strategies with sexual satisfaction and sexual intimacy in women with multiple sclerosis.多发性硬化症女性应对策略与性满意度及性亲密关系之间的联系。
Ann Gen Psychiatry. 2023 May 25;22(1):22. doi: 10.1186/s12991-023-00451-4.
8
Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis.实验性自身免疫性脑脊髓炎在解析肠道微生物群在多发性硬化症中的作用方面的优势与局限性。
Front Mol Neurosci. 2022 Nov 4;15:1019877. doi: 10.3389/fnmol.2022.1019877. eCollection 2022.
9
Predictors of Catching COVID-19 Infection during Pandemic Stage in Patients with Multiple Sclerosis (MS).多发性硬化症(MS)患者在大流行阶段感染新冠病毒的预测因素。
Int J Prev Med. 2022 Jul 15;13:102. doi: 10.4103/ijpvm.IJPVM_480_20. eCollection 2022.
10
Psychometric Properties of the Persian Version of the Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ) Questionnaire.多发性硬化症工作困难问卷(MSWDQ)波斯语版本的心理测量学特性。
Int J Prev Med. 2022 Jun 24;13:94. doi: 10.4103/ijpvm.IJPVM_393_20. eCollection 2022.
低身体残疾人群多发性硬化症的经济负担。
BMC Public Health. 2019 May 20;19(1):609. doi: 10.1186/s12889-019-6907-x.
4
What is the impact of socioeconomic status on multiple sclerosis?社会经济地位对多发性硬化症有何影响?
Neurology. 2019 Mar 26;92(13):e1536-e1539. doi: 10.1212/WNL.0000000000007166.
5
The prevalence of MS in the United States: A population-based estimate using health claims data.美国多发性硬化症的患病率:基于健康索赔数据的人群估计。
Neurology. 2019 Mar 5;92(10):e1029-e1040. doi: 10.1212/WNL.0000000000007035. Epub 2019 Feb 15.
6
A global perspective on the burden of multiple sclerosis.对多发性硬化症负担的全球视角。
Lancet Neurol. 2019 Mar;18(3):227-228. doi: 10.1016/S1474-4422(18)30498-8. Epub 2019 Jan 21.
7
Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家多发性硬化症负担 1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 Mar;18(3):269-285. doi: 10.1016/S1474-4422(18)30443-5. Epub 2019 Jan 21.
8
Geographic variations of multiple sclerosis in Iran: A population based study.伊朗多发性硬化症的地域差异:一项基于人群的研究。
Mult Scler Relat Disord. 2019 Feb;28:244-249. doi: 10.1016/j.msard.2019.01.001. Epub 2019 Jan 3.
9
Global and Regional Trends of Multiple Sclerosis Disability-Adjusted Life Years Rates: A 25-Year Assessment.全球和区域多发性硬化症残疾调整生命年率趋势:25 年评估。
Neuroepidemiology. 2019;52(1-2):17-24. doi: 10.1159/000492819. Epub 2018 Nov 26.
10
The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran.伊朗德黑兰多发性硬化症的患病率、发病率及家族复发情况。
Mult Scler Relat Disord. 2018 Oct;25:143. doi: 10.1016/j.msard.2018.07.023. Epub 2018 Jul 17.